What is the intrinsic value of EUCR?
As of 2025-08-26, the Intrinsic Value of Eucrates Biomedical Acquisition Corp. (EUCR) is
15.02 USD. This EUCR valuation is based on the model Peter Lynch Fair Value.
With the current market price of 10.04 USD, the upside of Eucrates Biomedical Acquisition Corp. is
49.61%.
Is EUCR undervalued or overvalued?
Based on its market price of 10.04 USD and our intrinsic valuation, Eucrates Biomedical Acquisition Corp. (EUCR) is undervalued by 49.61%.
15.02 USD
Intrinsic Value
EUCR Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
15.02 - 15.02 |
15.02 |
49.61% |
| P/E |
15.96 - 21.07 |
18.27 |
82.0% |
| DDM - Stable |
4.49 - 14.68 |
9.59 |
-4.5% |
| DDM - Multi |
7.46 - 19.40 |
10.82 |
7.8% |
EUCR Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
42.23 |
| Beta |
3.55 |
| Outstanding shares (mil) |
4.21 |
| Enterprise Value (mil) |
42.17 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.03% |
| Cost of Debt |
5.00% |
| WACC |
6.85% |